{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T01:51:04Z","timestamp":1773712264603,"version":"3.50.1"},"reference-count":68,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Department of Health's NIHR Queen Square Dementia Biomedical Research Unit"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","neurobiologyofaging.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.neurobiolaging.2015.08.026","type":"journal-article","created":{"date-parts":[[2015,9,4]],"date-time":"2015-09-04T07:33:25Z","timestamp":1441352005000},"page":"3140-3151","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":70,"title":["Genetic determinants of white matter hyperintensities and amyloid angiopathy in familial Alzheimer's disease"],"prefix":"10.1016","volume":"36","author":[{"given":"Natalie S.","family":"Ryan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geert-Jan","family":"Biessels","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lois","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer M.","family":"Nicholas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip A.","family":"Barber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phoebe","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priya","family":"Gami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huw R.","family":"Morris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9672-0202","authenticated-orcid":false,"given":"Ant\u00f3nio J.","family":"Bastos-Leite","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan M.","family":"Schott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jon","family":"Beck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"Mead","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucia","family":"Chavez-Gutierrez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bart","family":"de Strooper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin N.","family":"Rossor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamas","family":"Revesz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tammaryn","family":"Lashley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nick C.","family":"Fox","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2015.08.026_bib1","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s00401-009-0485-4","article-title":"Assessment of beta-amyloid deposits in human brain: a study of the BrainNet Europe Consortium","volume":"117","author":"Alafuzoff","year":"2009","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neurobiolaging.2015.08.026_bib2","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.3174\/ajnr.A3500","article-title":"MR imaging features of amyloid-related imaging abnormalities","volume":"34","author":"Barakos","year":"2013","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"10.1016\/j.neurobiolaging.2015.08.026_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/alzrt59","article-title":"Autosomal-dominant Alzheimer's disease: a review and proposal for the prevention of Alzheimer's disease","volume":"3","author":"Bateman","year":"2011","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.neurobiolaging.2015.08.026_bib4","first-page":"564","article-title":"Amyloid angiopathy in Alzheimer's disease","volume":"14","author":"Bergeron","year":"1987","journal-title":"Can. J. Neurol. Sci."},{"issue":"Pt 12","key":"10.1016\/j.neurobiolaging.2015.08.026_bib5","doi-asserted-by":"crossref","first-page":"3299","DOI":"10.1093\/brain\/awn261","article-title":"Consequence of Abeta immunization on the vasculature of human Alzheimer's disease brain","volume":"131","author":"Boche","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2015.08.026_bib6","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00401-006-0127-z","article-title":"Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry","volume":"112","author":"Braak","year":"2006","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neurobiolaging.2015.08.026_bib7","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1046\/j.1365-2990.2003.00457.x","article-title":"APOE epsilon 4 influences the pathological phenotype of Alzheimer's disease by favouring cerebrovascular over parenchymal accumulation of A beta protein","volume":"29","author":"Chalmers","year":"2003","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.neurobiolaging.2015.08.026_bib8","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1148\/rg.265055090","article-title":"Cerebral amyloid angiopathy: CT and MR imaging findings","volume":"26","author":"Chao","year":"2006","journal-title":"Radiographics"},{"key":"10.1016\/j.neurobiolaging.2015.08.026_bib9","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1038\/emboj.2012.79","article-title":"The mechanism of gamma-secretase dysfunction in familial Alzheimer disease","volume":"31","author":"Chavez-Gutierrez","year":"2012","journal-title":"EMBO J."},{"key":"10.1016\/j.neurobiolaging.2015.08.026_bib10","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1136\/jnnp.2009.204180","article-title":"Cerebral amyloid angiopathy related inflammation: three case reports and a review","volume":"82","author":"Chung","year":"2011","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2015.08.026_bib11","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.neurobiolaging.2010.09.030","article-title":"A\u00a0novel presenilin 1 mutation, I202F occurring at a previously predicted pathogenic site causing autosomal dominant Alzheimer's disease","volume":"32","author":"Church","year":"2011","journal-title":"Neurobiol. Aging"},{"issue":"Pt 2","key":"10.1016\/j.neurobiolaging.2015.08.026_bib12","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1093\/brain\/awq321","article-title":"Brain microbleeds and Alzheimer's disease: innocent observation or key player?","volume":"134","author":"Cordonnier","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2015.08.026_bib13","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/nm0498-452","article-title":"A\u00a0variant of Alzheimer's disease with spastic paraparesis and unusual plaques due to deletion of exon 9 of presenilin 1","volume":"4","author":"Crook","year":"1998","journal-title":"Nat. Med."},{"key":"10.1016\/j.neurobiolaging.2015.08.026_bib14","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/hmg\/7.1.43","article-title":"Estimation of the genetic contribution of presenilin-1 and -2 mutations in a population-based study of presenile Alzheimer disease","volume":"7","author":"Cruts","year":"1998","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neurobiolaging.2015.08.026_bib15","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1212\/01.WNL.0000130531.90205.EF","article-title":"Memory impairment, but not cerebrovascular disease, predicts progression of MCI to dementia","volume":"63","author":"DeCarli","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2015.08.026_bib16","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1161\/01.STR.30.8.1548","article-title":"Impact of apolipoprotein E epsilon4 and vascular disease on brain morphology in men from the NHLBI twin study","volume":"30","author":"DeCarli","year":"1999","journal-title":"Stroke"},{"key":"10.1016\/j.neurobiolaging.2015.08.026_bib17","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1161\/01.STR.0000125859.71051.83","article-title":"Interaction between hypertension, apoE, and cerebral white matter lesions","volume":"35","author":"de Leeuw","year":"2004","journal-title":"Stroke"},{"key":"10.1016\/j.neurobiolaging.2015.08.026_bib18","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0074-7696(06)54005-7","article-title":"A\u00a0two decade contribution of molecular cell biology to the centennial of Alzheimer's disease: are we progressing toward therapy?","volume":"254","author":"Dillen","year":"2006","journal-title":"Int. Rev. Cytol."},{"key":"10.1016\/j.neurobiolaging.2015.08.026_bib19","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1136\/jnnp.69.5.668","article-title":"Does APO epsilon4 correlate with MRI changes in Alzheimer's disease?","volume":"69","author":"Doody","year":"2000","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2015.08.026_bib20","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1212\/WNL.46.6.1592","article-title":"Cerebral amyloid angiopathy in the brains of patients with Alzheimer's disease: the CERAD experience, Part XV","volume":"46","author":"Ellis","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2015.08.026_bib21","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/ana.10810","article-title":"Clinical manifestations of cerebral amyloid angiopathy-related inflammation","volume":"55","author":"Eng","year":"2004","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neurobiolaging.2015.08.026_bib22","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1016\/S0140-6736(13)62426-5","article-title":"The G8 Dementia Research Summit\u2013a starter for eight?","volume":"382","author":"Fox","year":"2013","journal-title":"Lancet"},{"issue":"Pt 9","key":"10.1016\/j.neurobiolaging.2015.08.026_bib23","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1093\/brain\/122.9.1709","article-title":"The impact of different presenilin 1 and presenilin 2 mutations on amyloid deposition, neurofibrillary changes and neuronal loss in the familial Alzheimer's disease brain: evidence for other phenotype-modifying factors","volume":"122","author":"Gomez-Isla","year":"1999","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2015.08.026_bib24","doi-asserted-by":"crossref","first-page":"3455","DOI":"10.1161\/STROKEAHA.109.558197","article-title":"Patients with Alzheimer disease with multiple microbleeds: relation with cerebrospinal fluid biomarkers and cognition","volume":"40","author":"Goos","year":"2009","journal-title":"Stroke"},{"key":"10.1016\/j.neurobiolaging.2015.08.026_bib25","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/ana.410380219","article-title":"Apolipoprotein E epsilon 4 and cerebral hemorrhage associated with amyloid angiopathy","volume":"38","author":"Greenberg","year":"1995","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neurobiolaging.2015.08.026_bib26","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.neurobiolaging.2008.06.012","article-title":"Genetic screening of Alzheimer's disease genes in Iberian and African samples yields novel mutations in presenilins and APP","volume":"31","author":"Guerreiro","year":"2010","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2015.08.026_bib27","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1046\/j.1351-5101.2003.00707.x","article-title":"Rapidly reversible dementia in cerebral amyloid inflammatory vasculopathy","volume":"11","author":"Harkness","year":"2004","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.neurobiolaging.2015.08.026_bib28","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1161\/01.STR.31.6.1263","article-title":"Effect of the apolipoprotein E epsilon4 allele on white matter hyperintensities in dementia","volume":"31","author":"Hirono","year":"2000","journal-title":"Stroke"},{"key":"10.1016\/j.neurobiolaging.2015.08.026_bib29","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1552-6569.2006.00047.x","article-title":"Prevalence of white matter hyperintensities in a young healthy population","volume":"16","author":"Hopkins","year":"2006","journal-title":"J.\u00a0Neuroimaging"},{"key":"10.1016\/j.neurobiolaging.2015.08.026_bib30","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1002\/1531-8249(200011)48:5<806::AID-ANA18>3.0.CO;2-F","article-title":"Variant Alzheimer's disease with spastic paraparesis and cotton wool plaques is caused by PS-1 mutations that lead to exceptionally high amyloid-beta concentrations","volume":"48","author":"Houlden","year":"2000","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neurobiolaging.2015.08.026_bib31","doi-asserted-by":"crossref","first-page":"1957.e1","DOI":"10.1016\/j.neurobiolaging.2014.02.014","article-title":"Mutational analysis in early-onset familial Alzheimer's disease in Mainland China","volume":"35","author":"Jiao","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2015.08.026_bib32","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1749-6632.1996.tb34430.x","article-title":"Apolipoprotein E alleles and brain vascular pathology in Alzheimer's disease","volume":"777","author":"Kalaria","year":"1996","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.neurobiolaging.2015.08.026_bib33","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1212\/01.wnl.0000260066.98681.2e","article-title":"Course of cerebral amyloid angiopathy-related inflammation","volume":"68","author":"Kinnecom","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2015.08.026_bib34","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s00401-007-0336-0","article-title":"Cortical alpha-synuclein load is associated with amyloid-beta plaque burden in a subset of Parkinson's disease patients","volume":"115","author":"Lashley","year":"2008","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neurobiolaging.2015.08.026_bib35","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1750-1326-3-20","article-title":"Histopathological and molecular heterogeneity among individuals with dementia associated with Presenilin mutations","volume":"3","author":"Maarouf","year":"2008","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neurobiolaging.2015.08.026_bib36","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1016\/S0002-9440(10)64688-3","article-title":"Amyloid angiopathy and variability in amyloid beta deposition is determined by mutation position in presenilin-1-linked Alzheimer's disease","volume":"158","author":"Mann","year":"2001","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.neurobiolaging.2015.08.026_bib37","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0002-9440(10)62993-8","article-title":"Cerebral microvascular amyloid beta protein deposition induces vascular degeneration and neuroinflammation in transgenic mice expressing human vasculotropic mutant amyloid beta precursor protein","volume":"167","author":"Miao","year":"2005","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.neurobiolaging.2015.08.026_bib38","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1212\/WNL.41.4.479","article-title":"The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease","volume":"41","author":"Mirra","year":"1991","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2015.08.026_bib39","doi-asserted-by":"crossref","first-page":"781","DOI":"10.3233\/JAD-2010-100159","article-title":"Familial Alzheimer's disease mutations in presenilins: effects on endoplasmic reticulum calcium homeostasis and correlation with clinical phenotypes","volume":"21","author":"Nelson","year":"2010","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.neurobiolaging.2015.08.026_bib40","doi-asserted-by":"crossref","first-page":"22339","DOI":"10.1074\/jbc.M111.243063","article-title":"Mutagenesis mapping of the presenilin 1 calcium leak conductance pore","volume":"286","author":"Nelson","year":"2011","journal-title":"J.\u00a0Biol. Chem"},{"key":"10.1016\/j.neurobiolaging.2015.08.026_bib41","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1038\/nn0901-887","article-title":"The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Abeta protofibril formation","volume":"4","author":"Nilsberth","year":"2001","journal-title":"Nat. Neurosci"},{"key":"10.1016\/j.neurobiolaging.2015.08.026_bib42","doi-asserted-by":"crossref","first-page":"4815","DOI":"10.1038\/emboj.2011.372","article-title":"Phenylpiperidine-type gamma-secretase modulators target the transmembrane domain 1 of presenilin 1","volume":"30","author":"Ohki","year":"2011","journal-title":"EMBO J."},{"key":"10.1016\/j.neurobiolaging.2015.08.026_bib43","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1212\/WNL.47.1.190","article-title":"The apolipoprotein E epsilon 4 allele is associated with increased neuritic plaques and cerebral amyloid angiopathy in Alzheimer's disease and Lewy body variant","volume":"47","author":"Olichney","year":"1996","journal-title":"Neurology"},{"issue":"Pt 3","key":"10.1016\/j.neurobiolaging.2015.08.026_bib44","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1093\/brain\/113.3.721","article-title":"Familial cerebral amyloid angiopathy with nonneuritic amyloid plaque formation","volume":"113","author":"Plant","year":"1990","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2015.08.026_bib45","first-page":"2083","article-title":"Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease","volume":"148","author":"Premkumar","year":"1996","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.neurobiolaging.2015.08.026_bib46","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jalz.2012.11.007","article-title":"The global prevalence of dementia: a systematic review and metaanalysis","volume":"9","author":"Prince","year":"2013","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.neurobiolaging.2015.08.026_bib47","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/nrneurol.2015.10","article-title":"White matter hyperintensities, cognitive impairment and dementia: an update","volume":"11","author":"Prins","year":"2015","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.neurobiolaging.2015.08.026_bib48","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2217\/bmm.09.91","article-title":"Alzheimer's prevention initiative: a proposal to evaluate presymptomatic treatments as quickly as possible","volume":"4","author":"Reiman","year":"2010","journal-title":"Biomark Med."},{"key":"10.1016\/j.neurobiolaging.2015.08.026_bib49","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1093\/jnen\/62.9.885","article-title":"Cerebral amyloid angiopathies: a pathologic, biochemical, and genetic view","volume":"62","author":"Revesz","year":"2003","journal-title":"J.\u00a0Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.neurobiolaging.2015.08.026_bib50","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1136\/jnnp.52.12.1337","article-title":"Pathological findings correlated with magnetic resonance imaging in subcortical arteriosclerotic encephalopathy (Binswanger's disease)","volume":"52","author":"Revesz","year":"1989","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2015.08.026_bib51","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s00401-009-0501-8","article-title":"Genetics and molecular pathogenesis of sporadic and hereditary cerebral amyloid angiopathies","volume":"118","author":"Revesz","year":"2009","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neurobiolaging.2015.08.026_bib52","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1097\/NEN.0b013e3181fab558","article-title":"Characteristics of dyshoric capillary cerebral amyloid angiopathy","volume":"69","author":"Richard","year":"2010","journal-title":"J.\u00a0Neuropathol. Expneurol."},{"issue":"Pt 1","key":"10.1016\/j.neurobiolaging.2015.08.026_bib53","first-page":"e201","article-title":"Cerebral microbleeds in familial Alzheimer's disease","volume":"135","author":"Ryan","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2015.08.026_bib54","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.3233\/JAD-142325","article-title":"Spontaneous ARIA (amyloid-related imaging abnormalities) and cerebral amyloid angiopathy related inflammation in presenilin 1-Associated familial Alzheimer's disease","volume":"44","author":"Ryan","year":"2014","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.neurobiolaging.2015.08.026_bib55","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2217\/bmm.09.92","article-title":"Correlating familial Alzheimer's disease gene mutations with clinical phenotype","volume":"4","author":"Ryan","year":"2010","journal-title":"Biomark Med."},{"key":"10.1016\/j.neurobiolaging.2015.08.026_bib56","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1038\/nn.2858","article-title":"Potent amyloidogenicity and pathogenicity of Abeta43","volume":"14","author":"Saito","year":"2011","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2015.08.026_bib57","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s00401-014-1340-9","article-title":"Abeta immunotherapy for Alzheimer's disease: effects on apoE and cerebral vasculopathy","volume":"128","author":"Sakai","year":"2014","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neurobiolaging.2015.08.026_bib58","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1136\/jnnp.68.5.653","article-title":"Cerebral white matter lesions are not associated with apoE genotype but with age and female sex in Alzheimer's disease","volume":"68","author":"Sawada","year":"2000","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"issue":"Pt 3","key":"10.1016\/j.neurobiolaging.2015.08.026_bib59","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1093\/brain\/awh379","article-title":"Abeta-related angiitis: primary angiitis of the central nervous system associated with cerebral amyloid angiopathy","volume":"128","author":"Scolding","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2015.08.026_bib60","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s00401-009-0521-4","article-title":"Variations in the neuropathology of familial Alzheimer's disease","volume":"118","author":"Shepherd","year":"2009","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neurobiolaging.2015.08.026_bib61","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/j.1440-1789.2007.00766.x","article-title":"A\u00a0presenilin 1 mutation (L420R) in a family with early onset Alzheimer disease, seizures and cotton wool plaques, but not spastic paraparesis","volume":"27","author":"Shrimpton","year":"2007","journal-title":"Neuropathology"},{"key":"10.1016\/j.neurobiolaging.2015.08.026_bib62","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.jalz.2011.05.2351","article-title":"Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: recommendations from the Alzheimer's Association Research Roundtable Workgroup","volume":"7","author":"Sperling","year":"2011","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.neurobiolaging.2015.08.026_bib63","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/jnr.10392","article-title":"Alzheimer's disease with spastic paresis and cotton wool type plaques","volume":"70","author":"Tabira","year":"2002","journal-title":"J.\u00a0Neurosci. Res."},{"key":"10.1016\/j.neurobiolaging.2015.08.026_bib64","doi-asserted-by":"crossref","first-page":"10544","DOI":"10.1073\/pnas.1402171111","article-title":"Allosteric regulation of gamma-secretase activity by a phenylimidazole-type gamma-secretase modulator","volume":"111","author":"Takeo","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neurobiolaging.2015.08.026_bib65","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1093\/jnen\/61.3.282","article-title":"Two types of sporadic cerebral amyloid angiopathy","volume":"61","author":"Thal","year":"2002","journal-title":"J.\u00a0Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.neurobiolaging.2015.08.026_bib66","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1212\/WNL.0000000000000732","article-title":"Posterior white matter disease distribution as a predictor of amyloid angiopathy","volume":"83","author":"Thanprasertsuk","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2015.08.026_bib67","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1161\/01.STR.32.6.1318","article-title":"A\u00a0new rating scale for age-related white matter changes applicable to MRI and CT","volume":"32","author":"Wahlund","year":"2001","journal-title":"Stroke"},{"key":"10.1016\/j.neurobiolaging.2015.08.026_bib68","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.3233\/JAD-142628","article-title":"Microbleeds in atypical presentations of Alzheimer's disease: a comparison to dementia of the Alzheimer's type","volume":"45","author":"Whitwell","year":"2015","journal-title":"J.\u00a0Alzheimer's Dis."}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458015004431?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458015004431?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,30]],"date-time":"2019-08-30T01:43:38Z","timestamp":1567129418000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458015004431"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":68,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S0197458015004431"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2015.08.026","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic determinants of white matter hyperintensities and amyloid angiopathy in familial Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Aging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2015.08.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}